BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/7/2021 8:15:21 AM | Browse: 834 | Download: 2023
 |
Received |
|
2021-02-19 11:08 |
|
Peer-Review Started |
|
2021-02-19 11:13 |
|
First Decision by Editorial Office Director |
|
2021-05-12 18:18 |
|
Return for Revision |
|
2021-05-12 18:18 |
|
Revised |
|
2021-06-11 13:15 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-07-30 03:30 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-07-30 06:00 |
|
Articles in Press |
|
2021-07-30 06:00 |
|
Edit the Manuscript by Language Editor |
|
2021-08-08 21:48 |
|
Typeset the Manuscript |
|
2021-09-02 01:45 |
|
Publish the Manuscript Online |
|
2021-09-07 08:15 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Charitha Gangadharan, Rupa Ahluwalia and Alben Sigamani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alben Sigamani, MBBS, MD, MSc, Professor, Chief Scientific Officer, Numen Health, No. 19, 4th C Cross Koramangala Industrial, 5th Block, Area, Bengaluru 560095, Karnataka, India. dralbens@numenhealth.com |
| Key Words |
Insulin resistance; Renin–angiotensin system; Blood flow measurements; Inflammation; Thrombosis; Severity of COVID-19 |
| Core Tip |
Diabetes has been associated with an increased risk of developing coronavirus disease 2019 (COVID-19) as well as more severe outcomes as a consequence. The pathogenetic link between insulin resistance and COIVD-19 disease severity is not fully understood. Establishing an association between insulin resistance and COVID-19 severity can help to develop targeted therapeutic interventions and potentially improve outcomes amongst the at-risk group. |
| Publish Date |
2021-09-07 08:15 |
| Citation |
Gangadharan C, Ahluwalia R, Sigamani A. Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity. World J Diabetes 2021; 12(9): 1550-1562 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i9/1550.htm DOI |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i9.1550 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
